These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 9111597)
1. A new strategy for treating patients with CD7+, CD4-, CD8- acute lymphoblastic leukaemia. Ono K; Yoshida T; Tsuchiya K; Nakazato S; Nagumo F; Shimamoto Y Eur J Haematol; 1997 Feb; 58(2):130-2. PubMed ID: 9111597 [No Abstract] [Full Text] [Related]
2. Circulating CD4+ T lymphocytes with intracellular but no surface CD3 antigen in five of seven patients consecutively diagnosed with angioimmunoblastic T-cell lymphoma. Serke S; van Lessen A; Hummel M; Szczepek A; Huhn D; Stein H Cytometry; 2000 Jun; 42(3):180-7. PubMed ID: 10861691 [TBL] [Abstract][Full Text] [Related]
3. Complete remission in a patient with hypoplastic acute lymphoblastic leukemia induced by granulocyte-colony-stimulating factor. Hatta Y; Iwata T; Takeuchi J; Ohshima T; Horie T Acta Haematol; 1995; 94(1):39-43. PubMed ID: 7544523 [TBL] [Abstract][Full Text] [Related]
4. Intensive therapy for adult acute lymphoblastic leukemia: preliminary results of the idarubicin/vincristine/L-asparaginase/prednisolone regimen. Bassan R; Battista R; Viero P; Pogliani E; Rossi G; Lambertenghi-Deliliers G; Rambaldi A; D'Emilio A; Buelli M; Borleri G Semin Oncol; 1993 Dec; 20(6 Suppl 8):39-46. PubMed ID: 7507263 [TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of immunological dissection in T-ALL: a report on 20 cases with stem cell (CD7+, CD4-, CD8-, CD1-) phenotype. Ferrara F; Cimino R; Antinolfi I; De Rosa C; Mele G; Mettivier V; Fusco C; Del Vecchio L Am J Hematol; 1992 Jun; 40(2):98-102. PubMed ID: 1375001 [TBL] [Abstract][Full Text] [Related]
6. Acute lymphoblastic leukaemia presenting as breast mass. Jain AK; Gupta RC; Bhardwaj B; Leelani N J Assoc Physicians India; 1992 May; 40(5):335-6. PubMed ID: 1483996 [TBL] [Abstract][Full Text] [Related]
7. Phenotypic changes in neutrophil granulocytes after G-CSF administration in patients with acute lymphoblastic leukemia under chemotherapy. Zarco MA; Ribera JM; Villamor N; Balmes A; Urbano Ispizua A; Feliu E Haematologica; 1998 Jun; 83(6):573-5. PubMed ID: 9676035 [TBL] [Abstract][Full Text] [Related]
8. CD7+ stem cell leukemia/lymphoma. Features of a subgroup without circulating blast cells. Katsuno M; Abe Y; Taguchi F; Yufu Y; Sadamura S; Goto T; Takatsuki H; Nishimura J; Hirata J; Akiyoshi T Cancer; 1993 Jul; 72(1):99-104. PubMed ID: 7685244 [TBL] [Abstract][Full Text] [Related]
9. CD7+, CD4-/CD8- acute leukemia with t(11;14)(p15;q11) in a child. Silva ML; de Oliveira MS; Valente AN; Abdelhay E; Bouzas LF; Laun L; Ribeiro RC Cancer Genet Cytogenet; 1991 Oct; 56(2):171-6. PubMed ID: 1721862 [TBL] [Abstract][Full Text] [Related]
15. Beau's lines after chemotherapy for ALL. Miyoshi I; Kubota T; Taguchi H Intern Med; 2007; 46(1):61. PubMed ID: 17202738 [No Abstract] [Full Text] [Related]
16. Biological characteristics of CD7(+) acute leukemia. Miwa H; Nakase K; Kita K Leuk Lymphoma; 1996 Apr; 21(3-4):239-44. PubMed ID: 8726405 [TBL] [Abstract][Full Text] [Related]
17. Decrease in number of CD16(Leu 11)+CD45RA(2H4)+ cells and defective production of natural killer cytotoxic factor in childhood acute lymphoblastic leukemia. Yamada S; Komiyama A Leuk Res; 1991; 15(9):785-90. PubMed ID: 1833597 [TBL] [Abstract][Full Text] [Related]
18. Quality control in immunophenotyping. Use of human CD4+ and CD8+ T clones as standards. Kunkl A; Valle MT; Fenoglio D; Manca F Ann N Y Acad Sci; 1993 Mar; 677():417-9. PubMed ID: 8494229 [No Abstract] [Full Text] [Related]
19. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside. Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468 [TBL] [Abstract][Full Text] [Related]
20. Persistence of peripheral blood and bone marrow blasts during remission induction in adult acute lymphoblastic leukemia confers a poor prognosis depending on treatment intensity. Cortes J; Fayad L; O'Brien S; Keating M; Kantarjian H Clin Cancer Res; 1999 Sep; 5(9):2491-7. PubMed ID: 10499624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]